Optivia provides transporter assays for drug discovery companies. Transporter assays are an important part of preclinical safety assessment. The FDA is particularly interested in them for the potential to cause drug interactions.

Optivia assays are well differentiated from other commercially available services because ours are performed in polarized mammalian cells while other companies use insect vesicles or frog oocytes.

Optivia Biotechnology Website

• Contact:
  115 Constitution Drive #7
  Menlo Park, CA, 94025
  United States
• David Lustig
  Vice President, Business Development
  +650-324-3177
  DLustig@optiviabio.com
  


• Organization Type: Clinical Research Organization

• Essinova member since May 24, 2009